The University of Texas MD Anderson Cancer Center
United States of America (USA)
Time frame: 1 June 2025 - 30 May 2026Profile
The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group of researchers. The Nature Index provides absolute Count of primary research articles and fractional Share counts of author contribution to articles. The positions in the table below reflect The University of Texas MD Anderson Cancer Center's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the corresponding table where The University of Texas MD Anderson Cancer Center is listed.
Position by research output Share
Position by research output Share in subject areas
Research
The University of Texas MD Anderson Cancer Center has the following research output in the current window (1 June 2025 - 30 May 2026) of the Nature Index. Click on Count to view a list of articles representing the corresponding Share value.
Overall research output
Research outputs by subject area
Leading research topics
In the Current Index (12-month rolling window), The University of Texas MD Anderson Cancer Center published the most articles in these research topics. Learn more about Nature Research Intelligence Topics.
| Topics | Count | Share |
|---|---|---|
| Oncology and Carcinogenesis | 228 | 51.80 |
| Bioinformatics and Computational Biology | 35 | 11.85 |
| Clinical Sciences | 47 | 9.09 |
| Neurosciences | 10 | 4.98 |
| Immunology | 43 | 4.80 |
| Genetics | 14 | 4.29 |
| Cardiovascular Medicine and Haematology | 17 | 3.55 |
Share output for the past 5 years
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.
Collaboration
Nature Index collaborations highlight fruitful collaborations that lead to high quality research around the world. A collaboration can be between any two institutions or locations co-authoring at least one article in the journals tracked by the Nature Index. The collaboration score between two institutions is the sum of each of their Shares on the papers to which both have contributed. The table and charts below highlight the leading collaborators with The University of Texas MD Anderson Cancer Center.
Top 5 domestic collaborators with The University of Texas MD Anderson Cancer Center by Share
Collaborating institutions
Note: Hover over the bars to view details about each institution's Share.
| Collaborating Institution | Collaborators' Share | Collaboration Score |
|---|---|---|
| Harvard University | 12.63 / 23.75 | 36.39 |
| The University of Texas Health Science Center at Houston (UTHealth) | 25.52 / 10.13 | 35.65 |
| Baylor College of Medicine (BCM) | 17.32 / 7.94 | 25.26 |
| University of Texas Graduate School of Biomedical Sciences (GSBS) | 15.45 / 2.22 | 17.67 |
| Massachusetts General Hospital (MGH) | 7.80 / 3.18 | 10.97 |
Top 5 international collaborators with The University of Texas MD Anderson Cancer Center by Share
Collaborating institutions
Note: Hover over the bars to view details about each institution's Share.
| Collaborating Institution | Collaborators' Share | Total Share |
|---|---|---|
| Sun Yat-sen University (SYSU) | 2.77 / 2.79 | 5.57 |
| Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) | 3.24 / 2.29 | 5.53 |
| University of Toronto (U of T) | 2.62 / 2.50 | 5.12 |
| MD Anderson Cancer Center Madrid | 3.39 / 1.18 | 4.56 |
| National Institute for Health and Medical Research (INSERM) | 2.26 / 0.75 | 3.00 |
Job finder
-
Postdoctoral Fellowships in Computational Biology
The University of Texas MD Anderson Cancer Center Houston, Texas (US) -
Postdoctoral Fellow – EXPERIMENTAL LUNG CANCER BIOLOGY, IMMUNOLOGY, AND INTERCEPTION
The University of Texas MD Anderson Cancer Center Houston, Texas (US)
View more job listings on Nature Careers.
Latest supplements
Nature Index 2026 Regenerative medicine
Regenerative medicine has the potential to transform the treatment of chronic and life-threatening diseases. But major challenges remain, such as overcoming immune rejection and ensuring that new therapies are developed using more inclusive data sets. In this supplement, we explore the discoveries that are driving the field, the barriers that could limit its progress, and the teams and institutions that are making their mark.
Nature Index 2026 Nanoscience and nanotechnology
From programmable RNA architectures to next-generation materials for energy and healthcare, researchers are harnessing the unusual properties of the nanoscale to tackle some of society's biggest challenges. This supplement explores the discoveries that are driving the field, the hurdles that remain and the institutions that are leading in nanoscience and nanotechnology research.
Relationships
Affiliated institutions
The following affiliated institutions are wholly owned, operated, administered or contains research facilities for The University of Texas MD Anderson Cancer Center. All affiliations for an affiliated institution are credited to the institution to which it is affiliated. Each of the affiliated institutions listed below has its own research profile.
- The University of Texas MD Anderson Cancer Center
Affiliated joint institutions and consortia
Represents joint institutions and consortia for which the institution is designated as a partner institution. Each partner institution of a joint institution or consortium receives an equivalent Share for every affiliation in which the consortium is included.
- Banner MD Anderson Cancer Center
- Break Through Cancer
- CLL Research Consortium (CRC)
- Center for RNA Interference and Non-Coding RNAs (RNA Center)
- Community Health Network MD Anderson Cancer Center
- Global BPGen Consortium
- Gulf Coast Consortia (GCC)
- ICGC Bone Cancer Project: Osteosarcoma/Chondrosarcoma/Rare Subtypes
- Immatics US, Inc.
- International Lung Cancer Consortium (ILCCO)
- MD Anderson Cancer Center at Cooper
- MD Anderson Cancer Center/UTHealth Department of Dermatology
- Mays Cancer Center
- MicroArray Quality Control (MAQC) Consortium
- Neurodegeneration Consortium (NDC)
- Parker Institute for Cancer Immunotherapy
- Program in Developmental Biology
- Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) Consortium
- Rolanette and Berdon Lawrence Bone Disease Program of Texas
- Texas Medical Center Digestive Diseases Center (TMC DDC)
- Texas Therapeutics Institute (TTI)
- University of Texas Graduate School of Biomedical Sciences (GSBS)